James N. Hadfield

Oncology R&D
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals?

Beyond Circulating Tumor DNA for Efficacy: Can We Use Cell-Free DNA to Detect and Monitor Toxicity Signals?

Journal: JCO precision oncology

Published: May 21, 2026

Nextstrain automates real-time phylodynamic analysis of open data for endemic and emerging pathogens.

Nextstrain automates real-time phylodynamic analysis of open data for endemic and emerging pathogens.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Nextstrain automates real-time phylodynamic analysis of open data for endemic and emerging pathogens.

Nextstrain automates real-time phylodynamic analysis of open data for endemic and emerging pathogens.

Journal: bioRxiv : the preprint server for biology

Published: April 03, 2026

Enrichment of mutated DNA enables ultra-sensitive ctDNA detection in NSCLC using shallow targeted sequencing.

Enrichment of mutated DNA enables ultra-sensitive ctDNA detection in NSCLC using shallow targeted sequencing.

Journal: Scientific reports

Published: March 06, 2026

Unlocking the potential of urine-based liquid biopsy through improved reporting and standardization.

Unlocking the potential of urine-based liquid biopsy through improved reporting and standardization.

Journal: Nature reviews. Cancer

Published: September 25, 2025

A UK multicentre cohort study of clinical outcomes of distal femoral replacement for nononcological conditions : the EndoProsthetic Replacement for nonOncological conditions (EPRO) study.

A UK multicentre cohort study of clinical outcomes of distal femoral replacement for nononcological conditions : the EndoProsthetic Replacement for nonOncological conditions (EPRO) study.

Journal: The bone & joint journal

Published: May 31, 2025

A UK multicentre cohort study of clinical outcomes of proximal femoral replacement for nononcological conditions : the EndoProsthetic Replacement for nonOncological conditions (EPRO) study.

A UK multicentre cohort study of clinical outcomes of proximal femoral replacement for nononcological conditions : the EndoProsthetic Replacement for nonOncological conditions (EPRO) study.

Journal: The bone & joint journal

Published: May 31, 2025

Reply to S. Sorscher.

Reply to S. Sorscher.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 11, 2024

Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?

Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 16, 2024

Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples.

Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples.

Journal: Clinical epigenetics

Published: March 28, 2024

Validation and Performance of Quantitative BRCA1 and RAD51C Promoter Hypermethylation Testing in Breast and Ovarian Cancers.

Validation and Performance of Quantitative BRCA1 and RAD51C Promoter Hypermethylation Testing in Breast and Ovarian Cancers.

Journal: The Journal of molecular diagnostics : JMD

Published: February 09, 2024

Tracing household transmission of SARS-CoV-2 in New Zealand using genomics.

Tracing household transmission of SARS-CoV-2 in New Zealand using genomics.

Journal: Npj viruses

Published: December 19, 2023

Showing 1-12 of 74

Last Updated: 09/26/2026